Ozone News and Research

RSS

TSO3 revenue decreases to $7.7 million for fiscal year ending December 31, 2010

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, today reported sales for the fiscal year ending December 31, 2010 totalling $939,285 representing the sale of four new generation sterilizers to 3M for training purposes.

16 Mar 2011

Study: Role of air pollutants in cardiometabolic syndrome

To explore one of the most critical health/environment intersections - how the very air we breathe can cause heart disease and diabetes and contribute to the problems of obesity - Michigan State University has been named a Clean Air Research Center by the Environmental Protection Agency.

8 Mar 2011

BlueCross earns LEED Gold campus certification

BlueCross BlueShield of Tennessee announced today its certification as a LEED Gold campus, established by the U.S. Green Building Council and verified by the Green Building Certification Institute. LEED is the nationally accepted benchmark for the design, construction and operation of high-performance green buildings.

5 Mar 2011

AAFA study: Richmond ranked as No. 1 Asthma Capital in the U.S.

For the second year in a row, Richmond, VA, has been ranked as the No. 1 Asthma Capital – the most challenging place to live with asthma in the U.S. – according to the Asthma and Allergy Foundation of America, which conducted the study.

23 Feb 2011

New footprint calculator shows human impact on nitrogen cycle

People who want to eat healthy and live sustainably have a new way to measure their impact on the environment: a Web-based tool that calculates an individual's "nitrogen footprint."

23 Feb 2011

Teva reports positive results from QNAZE Phase III perennial allergic rhinitis trial

Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).

10 Feb 2011

TOMI announces joint venture agreement with Zera Investments

TOMI Environmental Solutions, Inc., a global green leader in infectious disease control and surface and air remediation, announced today a joint venture agreement with Zera Investments PTE. LTD, a Singapore private investment company.

7 Feb 2011

Bright light from sports stadiums, urban street lamps may boost daytime ozone levels

Not even the most avid fans could notice, but those spectacular aerial images of a brightly-lit Cowboys Stadium during Sunday's Super Bowl XLV symbolize one of the hottest new pieces of scientific intelligence about air pollution.

4 Feb 2011

Exposure to 'thirdhand smoke' poses additional health risks

Scientists are reporting that so-called "thirdhand smoke" - the invisible remains of cigarette smoke that deposits on carpeting, clothing, furniture and other surfaces - may be even more of a health hazard than previously believed. The study, published in ACS' journal, Environmental Science & Technology, extends the known health risks of tobacco among people who do not smoke but encounter the smoke exhaled by smokers or released by smoldering cigarette butts.

13 Jan 2011

Unclean vehicle cabin air filters more dangerous to children

Though air pollution is still a serious threat to public health, it appears to be even more so to the health of our children, recent studies show. Outdoors, indoors, and even while being driven with the windows rolled up, children are potentially more susceptible to the ill effects of pollution than adults.

16 Dec 2010

Researchers develop new method to reduce amount of radiation needed to kill pathogens

A team of Texas AgriLife Research engineers has developed a way to cut by as much as half the amount of irradiation needed to kill 99.999 percent of salmonella, E. coli and other pathogens on fresh produce.

7 Dec 2010

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR), that demonstrated significantly greater symptom relief compared with placebo.

15 Nov 2010

Electrolytic Ozone completes Series A funding

Electrolytic Ozone Inc. (EOI) today announced completion of Series A funding. EOI develops and manufactures ultra-compact, safe and reliable ozone generators that harness the benefits of ozone to improve the safety and quality of the human environment. EOI ozone cells enable innovative sanitization, deodorization and preservation applications of ozone for consumer, food safety, health and medical uses.

4 Nov 2010

TSO3 third quarter revenue decreases from $126,162 to $122,759

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted revenues of $122,759 for the third quarter of 2010, ended September 30, for the sale of accessories and service contracts.

3 Nov 2010

Progress in understanding mechanism behind photocontact allergy

What happens to sunscreens when they are exposed to sunlight? And how is the skin affected by the degradation products that form? This has been the subject of research at the University of Gothenburg and Chalmers University of Technology that will be presented at the upcoming dermatologist conference in Gothenburg.

11 Oct 2010

Researchers find exposure to air pollution increases severity of asthma symptoms

Exposure to dirty air is linked to decreased function of a gene that appears to increase the severity of asthma in children, according to a joint study by researchers at Stanford University and the University of California, Berkeley.

6 Oct 2010

Pollution increases risk for sudden cardiac arrest

The fine particles of pollution that hang in the air can increase the risk for sudden cardiac arrest, according to a new study conducted by a team from Long Island Jewish (LIJ) Medical Center and The Feinstein Institute for Medical Research.

21 Sep 2010

CreAgri receives patent for Hydroxytyrosol for skin damage by UV exposure

CreAgri, Inc. announced today that the company has received a Patent by the Australian Patent Office, Patent Number 2003249719, which covers the protective effects provided by Hydroxytyrosol against skin damage caused by UV exposure.

26 Aug 2010

TOPEX announces sale of skin cancer business operations to SENSUS Healthcare

TOPEX, Inc. announces the sale of its skin cancer business operations to SENSUS Healthcare, LLC for its low energy SRT 100 superficial radiotherapy treatment system. Since TOPEX received FDA approval during 2007, many systems have been operating worldwide at hospital radiation oncology centers, dermatology and veterinary oncology practices for the treatment of skin cancer.

19 Aug 2010

Ozone, nicotine reaction may become threat to asthma sufferers: Study

Another reason for including asthma on the list of potential health risks posed by secondhand tobacco smoke, especially for non-smokers, has been uncovered. Furthermore, the practice of using ozone to remove the smell of tobacco smoke from indoor environments, including hotel rooms and the interiors of vehicles, is probably a bad idea.

17 Aug 2010